(Q37677121)

21 August 2017

Bortezomib inhibits C2C12 growth by inducing cell cycle arrest and apoptosis (English)

1 reference

21 August 2017

0 references

11

1 reference

21 August 2017

S S Xing

1

1 reference

21 August 2017

C C Shen

2

1 reference

21 August 2017

M P Godard

3

1 reference

21 August 2017

J J Wang

4

1 reference

21 August 2017

Y Y Yue

5

1 reference

21 August 2017

S T Yang

6

1 reference

21 August 2017

Q Zhao

7

1 reference

21 August 2017

S B Zhang

8

1 reference

21 August 2017

T X Wang

9

1 reference

21 August 2017

X L Yang

10

1 reference

21 August 2017

Y He

12

1 reference

21 August 2017

Y H Song

13

1 reference

21 August 2017

language of work or name

English

0 references

publication date

10 February 2014

1 reference

Biochemical and Biophysical Research Communications

21 August 2017

1 reference

21 August 2017

445

1 reference

21 August 2017

2

1 reference

21 August 2017

375-380

1 reference

describes a project that uses

21 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3971480/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Proteasome inhibition prolongs survival during lethal hemorrhagic shock in rats

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Cardiotoxicity of the anticancer therapeutic agent bortezomib.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

An update on promising agents for the treatment of cancer cachexia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Targeting the UPS as therapy in multiple myeloma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Drug discovery in the ubiquitin-proteasome system.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Pharmacology, pharmacokinetics, and practical applications of bortezomib

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

A phase 2 study of bortezomib in relapsed, refractory myeloma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

The proteasome: a new target for novel drug therapies

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Proteasome inhibitors: from research tools to drug candidates

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

17β-estradiol protects mitochondrial functions through extracellular-signal-regulated kinase in C2C12 muscle cells

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Bortezomib partially protects the rat diaphragm from ventilator-induced diaphragm dysfunction

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Proteasome inhibition improves diaphragm function in an animal model for COPD.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Reduction of skeletal muscle atrophy by a proteasome inhibitor in a rat model of denervation

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Caspase activation contributes to endotoxin-induced diaphragm weakness

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3971480

Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24525132

12 December 2020

inferred from PubMed ID database lookup

Calpain and caspase-3 play required roles in immobilization-induced limb muscle atrophy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24525132

12 December 2020

inferred from PubMed ID database lookup

Burn-induced increase in atrogin-1 and MuRF-1 in skeletal muscle is glucocorticoid independent but downregulated by IGF-I

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24525132

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/J.BBRC.2014.02.008

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24525132

1 reference